Explore Boston Scientific CRT-Ds and ICDs that feature HeartLogic, the first and only FDA-approved heart failure diagnostic that uses multiple sensors to track physiological trends, combines them into one composite index and sends proactive alerts of worsening heart failure.1 Your extraordinary talent. Our extraordinary technology. Together, we can change the future of electrophysiology and heart failure management.
Our groundbreaking line of data-driven CRT-Ds gives you unprecedented insight and control, while offering an extraordinary, holistic approach to cardiac care. New technology may help you accurately predict heart failure events weeks in advance2 and control programming to maximize response long-term. All with the battery power to fully leverage device capabilities. In your hands, CRT-D devices with HeartLogic turn reactive treatment into proactive care.
Our groundbreaking line of data-driven ICDs offers an extraordinary, holistic approach to cardiac care and puts unprecedented insight, control and power in your hands. New technology may allow you to accurately predict heart failure events weeks in advance2 and control programming to maximize response over the long-term. All with the battery power to fully leverage device capabilities. The future of heart failure management is here.
Features: ImageReady MR-Conditional Systems
Remote Patient Management
The PREDICt RM Study, a retrospective analysis of nearly 40,000 patients, found that patients using the LATITUDE™ Remote Patient Management System had a 33% reduction in the risk of death and a 19% decrease in all-cause hospitalizations compared to those who were not remotely monitored.3
LATITUDE™ NXT Remote Patient Management System
LATITUDE™ NXT enables patients' cardiac health and implanted device data to be remotely followed between scheduled office appointments. The HeartLogic index, individual trend data and the actionable HeartLogic alert are available within LATITUDE™ NXT and provide a median of 34 days advance notice of worsening heart failure and <2 alerts per patient per year.
Patient Management Portfolio
Explore our complete portfolio of remote patient management products that give you the critical insights you need to make better, quicker decisions during the implant procedure and beyond.
The Power to Do What Others Cannot
Clinically proven to have the industry’s longest battery life, devices powered with EnduraLife™ Battery Technology reduce the risk of infections and complications due to changeouts. Now, you’re empowered to enable HeartLogic without compromising device longevity.
Stay Up to Date
Sign up here to receive emails about major conferences, clinical studies and technology updates.
Explore clinical data, workflow tools and other resources to help you implement and use HeartLogic in your practice.
1.Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017 Mar;5(3):216-25.
2. Boehmer, J et al., JACC-HF, 2017;5(3),2 1 6 – 2 56.
3. Akar J, et al “Use of remote monitoring is associated with improved outcomes among patients with implantable cardioverter-defibrillators” HRS 2014; Abstract LB03-03.